Built for Rare. Driven by Purpose.
Curant Rare is the next generation of rare disease specialty pharmacy, where compassionate support, and real-world insights converge to deliver extraordinary outcomes.
Driving better outcomes, together
For over 25 years, we’ve improved the lives of patients by challenging the status quo. We transform every rare disease journey through compassionate, high-touch care, ensuring access to critical therapies, removing barriers, and leveraging real-time insights and real-world evidence to guide personalized treatment. By partnering closely with patients, providers, and manufacturers, we deliver meaningful support at every step, making complex care simple, connected, and impactful. As the bridge between patients, caregivers, and the broader rare disease community, we make sure every individual feels supported, empowered, and connected to the communities that understand their journey best.
Where Rare Meets Remarkable
%
Aggregated Adherence Rate Measured as Total PDC Across All Member Populations
%
Highly Satisfied Providers Bridging the gap between member, plan & provider
Net Promoter Score (NPS) Validating Our Best-in-Class Member Satisfaction
Institutional Review Board (IRB) Clinical Studies Validating Our Outcomes
Years of independence and and proven success in patient-centered care.
Redefining Rare Care
Every patient has a story. Every treatment, intervention, and program we deliver touches a life, helping patients feel supported, empowered, and cared for.
The Bespoke Rare Disease Specialty Pharmacy
Programs & Services
High Touch Patient, Caregiver & Provider Support
Curant Rare is empowered by Medication Care Management®, our signature high-touch approach that goes beyond traditional therapy management:
-
We provide continuous, personalized support for patients, caregivers, and providers to ensure lasting adherence and improved outcomes throughout the rare disease journey.
-
By taking a longitudinal and relational approach, we help patients maintain consistency in their treatment while giving providers the insights they need to make informed, proactive care decisions.
Our implementation and commercial teams bring centuries of combined industry and data expertise to deliver the best possible experience
Our dedicated pharmacists and robust clinical team ensure optimal patient access by focusing on and eliminating barriers to therapy
Every patient and caregiver has a dedicated team providing comprehensive care and personalized support to manage the rare journey
Compassionate Use Expanded Access Programs (EAPs)
Curant Rare delivers full-service support for Expanded Access Programs, managing logistics, regulatory requirements, and communication so innovative therapies reach patients safely and efficiently.
- Our high-touch, compassionate model supports patients and providers at every step; streamlining processes, simplifying documentation, and ensuring clear education and follow-up.
- By connecting patients, providers, and manufacturers, we accelerate access to life-changing therapies and create meaningful impact for those who need it most.
Eliminate the inefficiencies for your Expanded Access Program and your commercial distribution strategy
Through the EAP, we model your commercial program to ensure a seamless launch at approval
As your early access and commercial partner, we are fully invested in your product’s long-term success
Realtime Commercial Data & Real World Evidence
Curant Rare leverages Real-Time Insights (RTI) and Real-World Evidence (RWE):
- By collecting Patient Reported Outcomes (PROs) and analyzing treatment trends, we provide actionable insights that demonstrate both patient impact and program effectiveness.
-
We provide pharma partners with daily patient status reporting, ensuring complete visibility into each patient’s journey at all times. Our streamlined, reliable data delivery removes the administrative burden while supporting the detailed needs of rare disease programs.
-
Our approach ensures that every intervention, every interaction, and every care plan is accessible, actionable, and accountable to drive better outcomes.
We help our partners show the measurable impact of their therapies to payers, regulators, and stakeholders, strengthening market access and reimbursement strategies
Providing actionable insights directly from patients’ experiences, enabling more precise, evidence-based decisions from pre-PDUFA to post-marketing launch
Insights that reveal what matters to patients, tailored support programs, improved adherence, as well as providing actionable and meaningful results
Awards & Recognition

Grand Finalist - Microsoft's Innovation Award

HITRUST r2: 2-Year Validated Assessment

Inc. 5000 - Fastest Growing Privately-Held Companies

Inc.'s Most Inspiring Companies

Validated by 12 Institutional Review Boards
News & Resources
Recent Updates
Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics
Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics ATLANTA--(BUSINESS WIRE)--Curant Health is proud to announce that Curant Rare has been selected by Corcept Therapeutics as a specialty pharmacy to provide personalized care, coordinated access to...
Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™, the First and Only FDA-Approved Oral Maintenance Therapy Shown to Cut the Risk of High-Risk Neuroblastoma Relapse in Half
Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™, the First and Only FDA-Approved Oral Maintenance Therapy Shown to Cut the Risk of High-Risk Neuroblastoma Relapse in Half Atlanta, GA – August 18, 2025 – Curant Health is proud to announce that Curant...
Curant Health Launches Curant Rare™, A Specialized Division Dedicated to Rare & Orphan Disease Care
Curant Rare Selected By IntraBio as the Exclusive Specialty Pharmacy for AQNEURSA™ (levacetylleucine), the First Stand-Alone Therapy for Niemann-Pick Disease Type CATLANTA--(BUSINESS WIRE)--Curant Health, a multifaceted Medication Care Management® organization,...


